Apellis Pharmaceuticals (APLS) Insider Trading & Ownership $24.37 +0.04 (+0.16%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$23.70 -0.68 (-2.77%) As of 08/8/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$6.70M Get APLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APLS Insider Buying and Selling by Quarter Apellis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/17/2025Cedric FrancoisCEOSell19,725$20.21$398,642.25 7/16/2025David O WatsonGeneral CounselSell5,000$19.55$97,750.00 7/15/2025Cedric FrancoisCEOSell1,900$20.09$38,171.00 7/14/2025Cedric FrancoisCEOSell137,465$20.19$2,775,418.35 6/16/2025David O WatsonGeneral CounselSell5,000$18.77$93,850.00 3/17/2025James George ChopasCAOSell183$24.82$4,542.06 3/5/2025David O WatsonGeneral CounselSell5,569$25.10$139,781.90 2/11/2025Mark Jeffrey DelongInsiderSell363$28.54$10,360.02 1/29/2025Cedric FrancoisCEOSell2,824$29.52$83,364.48 1/29/2025David O WatsonGeneral CounselSell695$29.52$20,516.40 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/29/2025Nur NicholsonInsiderSell825$29.52$24,354.00 1/29/2025Timothy Eugene SullivanCFOSell546$29.52$16,117.92 1/22/2025Cedric FrancoisCEOSell13,551$30.43$412,356.93 1/22/2025David O WatsonGeneral CounselSell3,323$30.43$101,118.89 1/22/2025James George ChopasCAOSell1,096$30.43$33,351.28 1/22/2025Nur NicholsonInsiderSell3,948$30.43$120,137.64 1/22/2025Timothy Eugene SullivanCFOSell3,088$30.43$93,967.84 1/17/2025Cedric FrancoisCEOSell6,007$29.96$179,969.72 1/17/2025David O WatsonGeneral CounselSell2,201$29.96$65,941.96 1/17/2025James George ChopasCAOSell715$29.96$21,421.40 1/17/2025Nur NicholsonInsiderSell2,145$29.96$64,264.20 1/17/2025Timothy Eugene SullivanCFOSell1,730$29.96$51,830.80 1/13/2025Cedric FrancoisCEOSell6,247$28.70$179,288.90 1/13/2025David O WatsonGeneral CounselSell4,965$28.70$142,495.50 1/13/2025James George ChopasCAOSell783$28.70$22,472.10 1/13/2025Jeffrey EiseleInsiderSell264$28.70$7,576.80 1/13/2025Timothy Eugene SullivanCFOSell2,170$28.70$62,279.00 1/6/2025Caroline BaumalInsiderSell2,816$33.81$95,208.96 12/23/2024Jeffrey EiseleInsiderSell63$33.09$2,084.67 9/16/2024A. Sinclair DunlopDirectorSell37,000$36.23$1,340,510.00 (Data available from 1/1/2013 forward) APLS Insider Trading Activity - Frequently Asked Questions Who is on Apellis Pharmaceuticals' Insider Roster? The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Caroline Baumal, Cedric Francois, David O Watson, Federico Grossi, James George Chopas, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Nur Nicholson, Pascal Deschatelets, and Timothy Eugene Sullivan. Learn more on insiders at APLS. What percentage of Apellis Pharmaceuticals stock is owned by insiders? 6.50% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings. Which Apellis Pharmaceuticals insiders have been selling company stock? The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($3,860,569.58), Adam J Townsend ($299,644.96), Alec Machiels ($233,225.00), Caroline Baumal ($260,406.51), Cedric Francois ($28,449,606.70), David O Watson ($1,551,211.41), James George Chopas ($247,659.33), Jeffrey Eisele ($42,858.73), Lukas Scheibler ($600,000.00), Mark Jeffrey Delong ($580,440.96), Nur Nicholson ($1,809,030.44), Pascal Deschatelets ($8,651,477.64), and Timothy Eugene Sullivan ($1,315,269.78). How much insider selling is happening at Apellis Pharmaceuticals? Insiders have sold a total of 1,044,281 Apellis Pharmaceuticals shares in the last 24 months for a total of $47,901,401.04 sold. Apellis Pharmaceuticals Key ExecutivesDr. Cedric Francois M.D. (Age 52)Ph.D., Co-Founder, President, CEO & Director Compensation: $1.44MMr. Alec Machiels J.D. (Age 51)MBA, Co-Founder & Director Compensation: $90.62kMr. Timothy E. Sullivan (Age 53)CFO & Treasurer Compensation: $793.43kMr. Adam J. Townsend (Age 46)Chief Operating Officer Compensation: $770.44kMr. David O. Watson Esq. (Age 51)J.D., General Counsel Compensation: $764.37k3 recent tradesDr. Caroline R. Baumal M.D. (Age 56)Chief Medical Officer Compensation: $1.01MDr. Pascal Deschatelets Ph.D. (Age 54)Co-Founder & Chief Scientific Officer Compensation: $688.05kMr. James G. Chopas CPA (Age 57)VP, Corporate Controller & Chief Accounting Officer Ms. Meredith KayaSenior Vice President, Investor Relations & Strategic FinanceMs. Karen Lewis (Age 51)Chief People Officer More Insider Trading Tools from MarketBeat Related Companies Verona Pharma PLC American Depositary Share Insider Transactions BridgeBio Pharma Insider Transactions Blueprint Medicines Insider Transactions Roivant Sciences Insider Transactions Elanco Animal Health Insider Transactions Revolution Medicines Insider Transactions Grifols Insider Transactions TG Therapeutics Insider Transactions Nuvalent Insider Transactions CRISPR Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:APLS) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
